Search results for: 'SYSTEMS AND METHODS FOR AI-ASSISTED SURGERY'
- Did you mean
- systems ad methods for ai assisted surgery
- Related search terms
- For an AP projection of the elbow, the humeral epicondyles are positioned
- forecasted of digital transformation in industry
- forecasting the global imaging market for 2024
- forecasting the global imaging market for 2025®ions=236
- forecasting the global imaging market for 2025®ions=285
-
19 Dec 2025  |  Global  |  Technology Research
Emerging AI-Driven Platforms and Next-Generation Therapeutics: Innovations in Healthcare Analytics, Drug Discovery, Cancer Therapeutics, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) delivers strategic insights into breakthrough innovations shaping the future of healthcare, life sciences, and precision medicine. It highlights AI-driven platforms, advanced biologics, and digital health solutions that address critical challenges in accessibili...
$950.00 -
20 Feb 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell & Gene Therapy, Targeted Protein Degradation, Bacteriophage Therapeutics, and Advanced Drug Delivery
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides strategic insights into frontier innovations redefining therapeutic development, precision diagnostics, and immune modulating interventions. It showcases breakthroughs across engineered phage therapeutics, intracellular peptide platforms, advanced gene ...
$950.00 -
16 Oct 2026  |  Global  |  Market Research
Public Sector Healthcare Cloud Market, North America and Europe, 2026
Public Healthcare Cloud is Driving Healthcare Transformation through Trusted Data, AI Readiness, and Digital Sovereignty
Public healthcare organizations across North America and Europe are using cloud technologies to support modernization efforts that extend beyond infrastructure replacement. Cloud is increasingly being adopted to improve interoperability, enable secure data sharing, support analytics and AI initiatives, strengthen cybersecurity, and modernize clinic...
$2,450.00 -
14 Nov 2025  |  Global  |  Technology Research
Emerging Therapeutic Platforms and AI-driven Innovations in Biologics, Oncology, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides actionable insights across new developments in oncology, immunology, autoimmune disorders, and precision medicine, highlighting next-generation biologics, bispecific antibodies, kinase inhibitors, molecular glues, and antibody engineering platforms. The...
$950.00 -
09 Oct 2025  |  Global  |  Technology Research
Research and Development Opportunities in Organoid Platforms for Cancer Applications
Emerging Trends and Technologies in Organoid-Enabled Cancer Modeling, Drug Discovery, Precision Medicine, and Therapeutic Screening
This study explores the transformative potential of organoid technologies in advancing cancer research, precision medicine, and drug discovery. Organoids—3D cell culture systems derived from patient tumors—preserve tumor heterogeneity and provide physiologically relevant models for studying cancer biology, therapeutic response, and resistance mecha...
$4,950.00 -
19 Jun 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Drug Discovery, Protein Engineering, Genomic Diagnostics, Advanced Drug Delivery, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping drug discovery, diagnostics, and therapeutic delivery across oncology, infectious diseases, rare and metabolic disorders, neuromuscular and neurodegenerative conditions, diabetes, ophthalmol...
$950.00 -
24 Jun 2019  |  North America  |  Market Research
US Clinical Decision Support Systems Market, Forecast to 2024
A Growing Market with an Opportunity to be More than an Adjunct to the EHR
Clinical Decision Support (CDS) systems are poised to become the user interface of choice for clinical interaction with health IT, ultimately supplanting the EHR system as the primary health IT point of interface for clinicians. This is due the fact that CDS began as a way to deliver medical content and patient information to the caregiver. Unlike ...
$4,950.00
Special Price $3,712.50 save 25 %
-
02 Jun 2020  |  Global  |  Frost Radar
Frost Radar™: Artificial Intelligence for Healthcare IT, Global, 2020
Benchmarking Future Growth Potential
Frost & Sullivan research has identified the core areas in which artificial intelligence (AI)-enabled healtchcare IT solutions are most relevant for hospitals, physicians, and payers. Hospitals that have so far invested in AI-based financial solutions to automate patient access management, reimbursement eligibility matching, and computer-assisted ...
$4,950.00
Special Price $3,712.50 save 25 %
-
27 Apr 2026  |  Global  |  Technology Research
Beyond Chronological Age: Biological Age Tracking and Longevity Platforms
Biological Age Tracking Is Evolving Into a Data-Driven, Multi-Omics, AI-Integrated Paradigm That Enables Precise Measurement of Biomarkers, Risk Assessment, and Longitudinal Health Monitoring
Biological age tracking is emerging as a complementary approach to understanding human health, offering a more nuanced assessment of physiological state than chronological age alone. This report examines the evolving landscape of biological aging platforms, with a focus on molecular and omics-based technologies including epigenetic, proteomic, tran...
$4,950.00 -
24 Jun 2026  |  Global  |  Market Research
Top 5 Growth Opportunities in AI-Enabled Drug Discovery, 2026
Growing Precision Medicine Research is Driving Agile Partnerships with Newer OoC Technologies
As the industry continues to innovate across novel small- and large-molecule therapies, including RNA-targeted small molecules, cell and gene therapies, and mRNA therapies, pharma sponsors increasingly rely on partners for technology access, database generation and analysis, and preclinical and clinical research.These disruptions continue to drive ...
$2,450.00